← Browse by Condition
Medical Condition
leiomyosarcoma
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 3, Phase 1
NCT07169344 Phase 2
Recruiting
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
Enrollment
110 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Enrollment
325 pts
Location
United States, China...
Sponsor
Advenchen Laboratories, LLC
NCT06277154 Phase 2
Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Enrollment
148 pts
Location
China
Sponsor
HRYZ Biotech Co.
NCT06088290 Phase 3
Recruiting
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
Enrollment
450 pts
Location
United States, Austr...
Sponsor
PharmaMar
NCT06308419 Phase 1
Recruiting
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Enrollment
18 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT01793168
Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Enrollment
20,000 pts
Location
United States, Austr...
Sponsor
Sanford Health